Krones Ag · XETR:KRN
Krones — 9M 2020 Earnings Presentation
15 slides from Krones's earnings presentation, Nov 4, 2020
Slide 1: Krones 9 Months 2020 Preliminary Figures
KRONES 9 Months 2020 Preliminary Figures Conference Call November 04, 2020
Slide 2: The Global Impact of COVID-19 is severe, but long-term fundamentals remain intact
2 ｜ KRONES Conference Call November 04, 2020 JFH The Global Impact of COVID-19 is severe,… Travel Restrictions On-Trade Sales Supply Chain …but long-term Growth Fundamentals remain intact… Population Growth Middle Class Urbanization …and Krones is well positioned for the “New Normal”! Remote & Digit
Slide 3: Krones Highlights Q1 – Q3 2020
3 ｜ KRONES Conference Call November 04, 2020 Krones Highlights Q1 – Q3 2020 -22.2% 2,301 EURm 2,449 Sales (-15.3%) EURm New orders Free cash flow -58.4 6.0% EURm (PY -294.5 EURm) 147,3 EURm (PY 164,3 EURm; 5.7%) EBITDA margin
Slide 4: Order intake in Q3 clearly better than Q2 – but still affected by Covid 19
4 ｜ KRONES Conference Call November 04, 2020 Order intake in Q3 clearly better than Q2 – but still affected by Covid 19 4,084 3,959 1,126 1,069 2,301 2,449 − Order intake in Q3 2020 was 8% below prior -22.2% -15.3% year, but with a strong increase vs. Q2 2020 919 -8.2% 1,000 -25.0% (+37%). 750 844 −
Slide 5: Krones' sales split
5 ｜ KRONES Conference Call November 04, 2020 Krones` sales split Share of sales (Q1 – Q3) Europe 2018 2019 2020 CIS/Central Asia 36.6% 39.2% 33.1% 2018 2019 2020 2.3% 1.7% 2.0% China North America 35.9% 2018 2019 2020 2018 2019 2020 33.1% 6.8% 8.6% 6.7% 2.6% 14.6% 17.5% 18.6% 2.0% 18.6% 9.1% 13.8% 6
Slide 6: Personnel and material cost
6 ｜ KRONES Conference Call November 04, 2020 Personnel and material cost Personnel cost Q1 – Q3 (EURm) 945.1 848.3 838.2 786.5 − Short-term measures (reduction of over-time, short-time working, …) reduced personnel costs as 31.6 31.2 32.6 34.1 well as the further positive effects from structural mea
Slide 7: Cost savings compensate the negative sales effect on the EBITDA in Q3
7 ｜ KRONES Conference Call November 04, 2020 Cost savings compensate the negative sales effect on the EBITDA in Q3 − Cost savings in personnel and material costs compensate most of the negative effects from the decrease in sales on the EBITDA − EBITDA margin in Q3 with 6.0% was higher than prior yea
Slide 8: Development of sales and EBITDA per segment 9 months
8 ｜ KRONES Conference Call November 04, 2020 Development of sales and EBITDA per segment 9 months Segment Sales (EURm) 9 months EBITDA (EURm) 9 months Product filling Targets 2020 *** Product filling Growth EBITDA margin − The measures to reduce personnel and decoration +6% +6% -13% 8.7% 7.0% 8.3% c
Slide 9: Working capital to sales ratio increased
9 ｜ KRONES Conference Call November 04, 2020 Working capital to sales ratio increased Working capital* in % ROCE* in % (Q1-Q3) of sales (Q1-Q3) 15.5 28.8 28,3 − Due to lower prepayments and increase in 25.7 receivable regarding onsite installations postponed because of Covid 19 − Additionally the av
Slide 10: Free cash flow improved significantly by 236 EURm vs. prior year
10 ｜ KRONES Conference Call November 04, 2020 Free cash flow improved significantly by 236 EURm vs. prior year Q1 – Q3 (in EURm) 2020 2019 Earnings before taxes 26.7 61.4 − Change in working capital favorable developed +/– Other non-cash changes +176.6 +187.9 compared to last year +/– Changes in wor
Slide 11: Krones is very well positioned financially
11 ｜ KRONES Conference Call November 04, 2020 Krones is very well positioned financially Net cash, free credit lines and high equity ratio in Q3 Liquidity reserves > €1bn Equity in EURm and equity ratio in % Used credit lines 255 EURm 1,433 1,370 1,314 1,330 1,226 43.8% 43.2% Cash 177 EURm 41.3% 41.
Slide 12: Krones Outlook 2020
12 ｜ KRONES Conference Call November 04, 2020 Krones Outlook 2020 Revenue growth EBITDA margin ~-17% 5.5-6.0% Sales Equivalent to EBT margin ~€3.3bn 1.0-1.6% This outlook does not include any one-off expenses for impairments and structural measures for capacity adjustments. If further countries and
Slide 13: 13 ｜KRONES Conference Call November 04, 2020
13 ｜KRONES Conference Call November 04, 2020
Slide 14: Questions and Answers
14 ｜ KRONES Conference Call November 04, 2020 Questions and Answers ? …
Slide 15: Disclaimer
15 ｜KRONES Conference Call November 04, 2020 Disclaimer This investor presentation contains forward-looking statements that are based on current estimates, forecasts and assumptions made by KRONES AG management to the best of its knowledge and other information currently available to KRONES AG. The